Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-usage evaluation by disease state: developing protocols.

M L Enlow1

  • 1Saint Joseph Health Center, Kansas City, MO, USA.

Pharmacy Practice Management Quarterly
|June 6, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha 2-interferon for the common cold.

The Annals of pharmacotherapy·1992
Same journal

Survey of standards and guidelines for immunization delivery.

Pharmacy practice management quarterly·2001
Same journal

Somebody else's antibodies: the characteristics and roles of immune globulins.

Pharmacy practice management quarterly·2001
Same journal

Targeting vaccines based on underlying disease states.

Pharmacy practice management quarterly·2001
Same journal

Overcoming immunization disparities based on ethnicity.

Pharmacy practice management quarterly·2001
Same journal

Immunization and organ transplant donors and recipients.

Pharmacy practice management quarterly·2001
Same journal

Pregnancy and lactation in relation to vaccines and antibodies.

Pharmacy practice management quarterly·2001
See all related articles

Drug-usage evaluation (DUE) by disease state is detailed, with community-acquired pneumonia treatment serving as a case study. This evaluation provided baseline data for developing a pneumonia clinical pathway.

Area of Science:

  • Pharmacoeconomics
  • Clinical Pharmacy Practice
  • Healthcare Quality Improvement

Background:

  • Drug-usage evaluation (DUE) principles extend to disease-specific assessments.
  • Standardized criteria for selecting disease processes and key evaluation components are essential.
  • Developing and validating DUE protocols requires a systematic approach.

Purpose of the Study:

  • To review the framework for disease state drug-usage evaluations (DUEs).
  • To present a case study of a disease state DUE for community-acquired pneumonia.
  • To illustrate how DUE results can inform clinical pathway development.

Main Methods:

  • The study outlines criteria for disease process selection and key process identification.
  • It describes methods for developing initial DUE protocols and their validation.

Related Experiment Videos

  • A collaborative network of clinical pharmacists developed the preliminary protocol for community-acquired pneumonia.

    • Main Results:

    • A disease state DUE was conducted for community-acquired pneumonia treatment.
    • Outcome measures were incorporated into the evaluation.
    • The findings served as baseline data for a clinical pathway.

    Conclusions:

    • Disease state DUE is a viable approach for evaluating medication use in specific conditions.
    • Collaborative efforts in protocol development enhance DUE effectiveness.
    • DUE findings are crucial for evidence-based clinical practice guideline development, such as clinical pathways.